Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

North America Botulinum Toxin Market Forecast 2021-2028

Published by Inkwood Research Product code 1003286
Published Content info 123 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Botulinum Toxin Market Forecast 2021-2028
Published: May 11, 2021 Content info: 123 Pages
Description

KEY FINDINGS

The North America botulinum toxin market is forecasted to progress with a CAGR of 4.77% over the estimated period of 2021 to 2028. The region's market growth is facilitated by factors like the presence of combination therapies for facial rejuvenation products and the upsurge in the geriatric populace.

MARKET INSIGHTS

The North America botulinum toxin market growth analysis entails the assessment of Canada and the United States. Canada comprises several domestic and global players, intensely competing among themselves. While the majority of the population across eastern countries retire by the age of 60, the retirement age in Canada is 65, resulting in an additional five years of professional and social life. This aspect creates the need to appear energetic and young, thereby bolstering the demand for cosmetic procedures. As per the Government of Canada, the country's citizens choose non-invasive aesthetic treatments in order to minimize facial wrinkles and improve their appearances. Besides,

On the other hand, botulinum neurotoxin injections are used for both cosmetic and medical purposes. The three forms of botulinum toxins available for patients in Canada include botulinum toxin type A, with trade names Botox, Xeomin, and Dysport). According to the International Society of Aesthetic Plastic Surgery (ISAPS) 2018 Report, the country has 530 plastic surgeons contributing to the botulinum toxin market. Moreover, Daewoong Pharmaceutical's exclusive sales partner, Evolus, acquired the marketing approval of Nuceiva (botulinum toxin) in August 2018 from Health Canada. Hence, these factors are set to facilitate the market growth in Canada over the forecasting years.

COMPETITIVE INSIGHTS

Some of the key companies operating in the market are Medytox, Ipsen Pharma, Allergan PLC, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 36336

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. RELATED MARKET ANALYSIS: AESTHETIC FILLER MARKET
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING DEMAND FOR AESTHETIC PROCEDURES
    • 3.2.2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
    • 3.3.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
    • 3.3.3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY TYPE

  • 5.1. TYPE A
  • 5.2. TYPE B

6. MARKET BY APPLICATION

  • 6.1. COSMETIC APPLICATIONS
    • 6.1.1. GLABELLAR LINES
    • 6.1.2. LATERAL CANTHAL LINES (CROW'S FEET)
    • 6.1.3. FOREHEAD LINES
    • 6.1.4. OTHER COSMETIC APPLICATIONS
  • 6.2. NON-COSMETIC APPLICATIONS
    • 6.2.1. DYSTONIA
    • 6.2.2. CHRONIC MIGRAINE
    • 6.2.3. OPHTHALMOLOGIC DISORDERS
    • 6.2.4. OTHER NON-COSMETIC APPLICATIONS

7. MARKET BY END-USER

  • 7.1. HOSPITALS
  • 7.2. CLINICS AND OTHERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. KEY GROWTH ENABLERS
    • 8.1.2. KEY CHALLENGES
    • 8.1.3. KEY PLAYERS
    • 8.1.4. COUNTRY ANALYSIS
      • 8.1.4.1. UNITED STATES
      • 8.1.4.2. CANADA

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. PRODUCT LAUNCHES & DEVELOPMENTS
  • 9.2. COMPANY PROFILES
    • 9.2.1. ABBVIE INC (ALLERGAN PLC)
    • 9.2.2. EVOLUS INC
    • 9.2.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
    • 9.2.4. HUGEL INC
    • 9.2.5. IPSEN PHARMA
    • 9.2.6. MEDYTOX INC
    • 9.2.7. MERZ PHARMA
    • 9.2.8. REVANCE THERAPEUTICS INC
    • 9.2.9. US WORLDMEDS LLC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BOTULINUM TOXIN
  • TABLE 2: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12:
  • TABLE 13: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 14: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2020
  • FIGURE 6: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)
  • FIGURE 7: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020
  • FIGURE 9: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW'S FEET), 2021-2028 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 19: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
  • FIGURE 20: NORTH AMERICA BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
  • FIGURE 21: NORTH AMERICA BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 23: UNITED STATES BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 24: CANADA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
Back to Top